Atorvastatin Impurity 37 | CAS 88675-31-4 - Request Quote
Atorvastatin Impurity 37
| SZ CAT No: | SZ-A037133 |
| CAS No | 88675-31-4 |
| Mol.F. | C14H10BrFO |
| Mol.Wt. | 293.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Atorvastatin Impurity 37 is chemically 2-Bromo-1-(4-fluorophenyl)-2-phenylethan-1-one. Atorvastatin Impurity 37 is supplied with detailed characterization data compliant with regulatory guideline. Atorvastatin Impurity 37 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Atorvastatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 88675-31-4
Purchase 88675-31-4
Order 88675-31-4
Enquire 88675-31-4
price of 88675-31-4
88675-31-4 Supplier
88675-31-4 Manufacturer
88675-31-4 Exporter
buy high quality Atorvastatin Impurity 37
Purchase Atorvastatin Impurity 37
Atorvastatin Impurity 37 suppliers
Atorvastatin Impurity 37 manufacturers
Atorvastatin Impurity 37 price
Order Atorvastatin Impurity 37
Enquire Atorvastatin Impurity 37
Atorvastatin Impurity 37 cost
Atorvastatin Impurity 37 Supplier
Atorvastatin Impurity 37 Distributor
Atorvastatin Impurity 37 for Method Validation
Atorvastatin Reference Standard
Atorvastatin Impurity 37 for ANDA Filing
Atorvastatin Impurity 37 for Forced Degradation Studies
Atorvastatin Impurity 37 Identification Standards
Atorvastatin Impurity 37 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.